Overview

A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other

Status:
Completed
Trial end date:
2019-08-30
Target enrollment:
Participant gender:
Summary
The main objective of Part 1of this trial is to investigate the effect of co-administration of multiple doses of donepezil on the single-dose pharmacokinetics of BI 425809 in healthy subjects. In Part 2 the main objective is the investigation of the effect of co-administration of multiple doses of BI 425809 on the single-dose pharmacokinetics of donepezil in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
BI 425809
Donepezil